Ernie Marshall - Concepedia

Author

Ernie Marshall

Clatterbridge Cancer Centre NHS Foundation Trust

Also Known As

Alex Mitchell, Ernie Marshall

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Clatterbridge Cancer Centre NHS Foundation Trust University of Liverpool Royal Devon and Exeter Hospital Weston Park Cancer Centre Royal Liverpool and Broadgreen University Hospital NHS Trust

About

Ernie Marshall is an author at Clatterbridge Cancer Centre NHS Foundation Trust specializing in medicine, oncology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	465
2	Business	1	1	21
3	Health Sciences	1	1	194
4	Nursing	1	1	20
5	Allergy	1	1	63

Ernie Marshall

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer Charles Butts, Nevin Murray, Andrew W. Maksymiuk, Journal of Clinical Oncology	2005	420
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial Charles Butts, Andrew W. Maksymiuk, Glenwood Goss, Journal of Cancer Research and Clinical Oncology MedicineImmunologyClinical TrialsVaccine TrialPhase Iib	2011	194
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial Siow Ming Lee, Iftekhar Khan, Sunil Upadhyay, The Lancet Oncology	2012	176
MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients Ernie Marshall, Christopher Romaniuk, Paula Ghaneh, British Journal of Ophthalmology	2012	108
Increased killer immunoglobulin‐like receptor expression and functional defects in natural killer cells in lung cancer Suliman Yousef Alomar, Ernie Marshall, Derek Middleton, Immunology Inflammatory Lung DiseaseLung InflammationImmunologyImmune RegulationFunctional Defects	2011	63
Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors Suliman Yousef Alomar, Derek Middleton, Ernie Marshall, Human Immunology ImmunogeneticsCancer ImmunosurveillanceSolid TumorsImmunologyPathology	2010	55
SCG3 Transcript in Peripheral Blood Is a Prognostic Biomarker for REST-Deficient Small Cell Lung Cancer Alan C. Moss, Gregory M. Jacobson, Lauren Walker, Clinical Cancer Research	2008	52
B1-01: A multi-centre phase IIB randomized controlled study of BLP25 liposome vaccine (L-BLP25 or Stimuvax) for active specific immunotherapy of non-small cell lung cancer (NSCLC): updated survival analysis Charles Butts, Andrew W. Maksymiuk, Glenwood Goss, Journal of Thoracic Oncology MedicineImmunologyVaccine TrialTherapeutic VaccineMulti-centre Phase Iib	2007	47
Reconciling the principle of patient autonomy with the practice of informed consent: decision-making about prognostication in uveal melanoma Sharon A. Cook, Bertil Damato, Ernie Marshall, Health Expectations	2010	40
Sunitinib versus dacarbazine as first-line treatment in patients with metastatic uveal melanoma. Joseph J. Sacco, Paul Nathan, Sarah Danson, Journal of Clinical Oncology OphthalmologySunitinib Versus DacarbazineMetastatic Uveal MelanomaMetastatic UmPharmacology	2013	37

Page 1